Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

levonadifloxacin MeSH Supplementary Concept Data 2025


MeSH Supplementary
levonadifloxacin
Unique ID
C000706771
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000706771
Entry Term(s)
(12S)-8-(4-((2S)-2-aminopropanoyl)oxypiperidin-1-yl)-7-fluoro-12-methyl-4-oxo-1-azatricyclo(7.3.1.05,13)trideca-2,5,7,9(13)-tetraene-3-carboxylic acid
(S)-(-)-nadifloxacin
EMROK
EMROK O
L-Alanine, 1-((5S)-2-carboxy-9-fluoro-6,7-dihydro-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizin-8-yl)-4-piperidinyl ester
WCK 2349
alalevonadifloxacin
Pharm Action
beta-Lactamase Inhibitors
Registry Numbers
8WHH66L098
57B7E1D1TG
Related Numbers
57B7E1D1TG
Previous Indexing
Quinolones (2020-2023)
Heading Mapped to
*Quinolizines
*Fluoroquinolones
Frequency
9
Note
broad-spectrum anti-MRSA benzoquinolizine quinolone agent; alalevonadifloxacin is prodrug of levonadifloxacin
Source
Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e02297-17
Drug Des Devel Ther. 2019 Dec 24;13:4351-4365.
Date of Entry
2020/06/08
Revision Date
2022/11/02
levonadifloxacin Preferred
alalevonadifloxacin Related
WCK 2349 Related
(12S)-8-(4-((2S)-2-aminopropanoyl)oxypiperidin-1-yl)-7-fluoro-12-methyl-4-oxo-1-azatricyclo(7.3.1.05,13)trideca-2,5,7,9(13)-tetraene-3-carboxylic acid Related
EMROK Related
EMROK O Related
page delivered in 0.005s